Arrhythmogenic Left Ventricular Cardiomyopathy: From Diagnosis to Risk Management.
Alfredo MaurielloAnna Selvaggia RomaAntonia AscrizziRiccardo MolinariFrancesco S LoffredoAntonello D'AndreaVincenzo RussoPublished in: Journal of clinical medicine (2024)
Left ventricular arrhythmogenic cardiomyopathy is still poorly characterized. ALVC is characterized by fibrofatty replacement in the left ventricular myocardium, with variable phenotypic expression. Diagnosis is based on a multiparametric approach, including cardiac magnetic resonance (CMR) and genetic testing, and is important for sudden cardiac death (SCD) risk stratification and management. Recent guidelines have improved the management of left ventricular arrhythmogenic cardiomyopathy. Further studies are necessary to improve knowledge of this cardiomyopathy.
Keyphrases